Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs metoprolol vs magnesium sulfate for reducing blood loss during craniotomy
IRCT20141209020258N188Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Dexmedetomidine arm, Metoprolol arm and Magnesium sulfate arm (3 arms). Primary endpoints: Average hemoglobin, Bleeding and 2 more. Started Sep 2023; status: completed.
02
Drugs
dexmedetomidinemetoprololmagnesium sulfate
Beyond the preview
Go deeper on IRCT20141209020258N188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N188.